- Home
- RLMD vs PSFE Comparison
RLMD vs PSFE Comparison
Compare RLMD & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLMD | PSFE |
|---|---|---|
| Founded | 2004 | 1996 |
| Country | United States | United Kingdom |
| Employees | N/A | 3300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.7M | 374.1M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLMD | PSFE |
|---|---|---|
| Price | $7.19 | $7.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $10.25 | $10.15 |
| AVG Volume (30 Days) | ★ 542.6K | 490.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.24 | $5.95 |
| 52 Week High | $5.12 | $18.15 |
Technical Indicators
Market Signals| Indicator | RLMD | PSFE |
|---|---|---|
| Relative Strength Index (RSI) | 79.95 | 59.71 |
| Support Level | $3.65 | $6.58 |
| Resistance Level | N/A | $8.65 |
| Average True Range (ATR) | 0.47 | 0.42 |
| MACD | 0.20 | 0.20 |
| Stochastic Oscillator | 98.67 | 85.19 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About PSFE Paysafe Limited
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.